Elizabeth Holmes, former CEO of the now-defunct blood-testing technology company Theranos, recently learned a harsh lesson on the complexities and
Continue Reading Pitfalls of Attorney-Client Privilege and Tips for Corporate Officers and Employees
Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the
Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Lessons Learned From Centripetal’s Multi-Billion Dollar Damages Award Against Cisco
Centripetal Networks, Inc. (“Centripetal”), one of the fastest growing innovators in the cybersecurity space, leveraged its patent portfolio against Cisco
Continue Reading Lessons Learned From Centripetal’s Multi-Billion Dollar Damages Award Against Cisco
Is it Time to Re-evaluate (or Create) Your Document Retention Policy?
In the fast-paced and dynamic environment of startup and emerging companies, standard operating procedures and compliance matters may often fall
Continue Reading Is it Time to Re-evaluate (or Create) Your Document Retention Policy?
Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
Scribe Enters CRISPR-Based Collaboration with Biogen
On October 7, 2020, Scribe Therapeutics announced a collaboration with Biogen, to collaborate on CRISPR-based medicines for treating neurological
Continue Reading Scribe Enters CRISPR-Based Collaboration with Biogen